Chronic kidney disease
Chronic kidney disease is a progressive disease with no cure and high morbidity and
mortality that occurs commonly in the general adult population, especially in people with …
mortality that occurs commonly in the general adult population, especially in people with …
Membranous nephropathy: new pathogenic mechanisms and their clinical implications
E Hoxha, L Reinhard, RAK Stahl - Nature Reviews Nephrology, 2022 - nature.com
Membranous nephropathy (MN) is characterized histomorphologically by the presence of
immune deposits in the subepithelial space of the glomerular filtration barrier; its clinical …
immune deposits in the subepithelial space of the glomerular filtration barrier; its clinical …
Primary membranous nephropathy
WG Couser - Clinical Journal of the American Society of …, 2017 - journals.lww.com
Membranous nephropathy (MN) is a unique glomerular lesion that is the most common
cause of idiopathic nephrotic syndrome in nondiabetic white adults. About 80% of cases are …
cause of idiopathic nephrotic syndrome in nondiabetic white adults. About 80% of cases are …
A proposal for a serology-based approach to membranous nephropathy
AS De Vriese, RJ Glassock, KA Nath… - Journal of the …, 2017 - journals.lww.com
Primary membranous nephropathy (MN) is an autoimmune disease mainly caused by
autoantibodies against the recently discovered podocyte antigens: the M-type …
autoantibodies against the recently discovered podocyte antigens: the M-type …
Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up
K Dahan, H Debiec, E Plaisier… - Journal of the …, 2017 - journals.lww.com
Randomized trials of rituximab in primary membranous nephropathy (PMN) have not been
conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals …
conducted. We undertook a multicenter, randomized, controlled trial at 31 French hospitals …
Pathophysiological advances in membranous nephropathy: time for a shift in patient's care
P Ronco, H Debiec - The Lancet, 2015 - thelancet.com
Membranous nephropathy is a major cause of nephrotic syndrome of non-diabetic origin in
adults. It is the second or third leading cause of end-stage renal disease in patients with …
adults. It is the second or third leading cause of end-stage renal disease in patients with …
Membranous nephropathy
P Ronco, L Beck, H Debiec, FC Fervenza… - Nature reviews Disease …, 2021 - nature.com
Membranous nephropathy (MN) is a glomerular disease that can occur at all ages. In adults,
it is the most frequent cause of nephrotic syndrome. In~ 80% of patients, there is no …
it is the most frequent cause of nephrotic syndrome. In~ 80% of patients, there is no …
Primary glomerulonephritides
J Floege, K Amann - The Lancet, 2016 - thelancet.com
Most glomerulonephritides, even the more common types, are rare diseases. They are
nevertheless important since they frequently affect young people, often cannot be cured, and …
nevertheless important since they frequently affect young people, often cannot be cured, and …
[HTML][HTML] The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and …
G Fernández-Juárez, J Rojas-Rivera, AE van De Logt… - Kidney international, 2021 - Elsevier
A cyclical corticosteroid-cyclophosphamide regimen is recommended for patients with
primary membranous nephropathy at high risk of progression. We hypothesized that …
primary membranous nephropathy at high risk of progression. We hypothesized that …
Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy
E Hoxha, I Thiele, G Zahner, U Panzer… - Journal of the …, 2014 - journals.lww.com
Membranous nephropathy (MN) is the most common cause of nephrotic syndrome in adults,
with an uncertain clinical outcome. The characterization of the phospholipase A 2 receptor …
with an uncertain clinical outcome. The characterization of the phospholipase A 2 receptor …